Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María de la Fuente

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Pharmaceutics|February 26, 2022
The Potential of Nanomedicine to Unlock the Limitless Applications of mRNALaura Taina-González, María de la Fuente
Cancer Letters|March 31, 2023
Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapiesJenifer García-Fernández, María de la Fuente Freire
Cryobiology|February 16, 2025
Long term stability of preservative-free and lyophilized PRGF eye drops stored at different temperature conditions: in vitro comparative studyEduardo Anitua, María de la Fuente, Mohammad Hamdan Alkhraisat
Macromolecular Bioscience|February 1, 2008
Novel hyaluronan-based nanocarriers for transmucosal delivery of macromoleculesMaría de la Fuente, Begoña Seijo, María J Alonso
Plos One|February 14, 2013
Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse plateletsAmal Arachiche, María de la Fuente, Marvin T Nieman
Plos One|May 17, 2014
Platelet specific promoters are insufficient to express protease activated receptor 1 (PAR1) transgene in mouse plateletsAmal Arachiche, María de la Fuente, Marvin T Nieman
Biotechnology Advances|June 7, 2015
Nanoengineering of vaccines using natural polysaccharidesAna Sara Cordeiro, María José Alonso, María de la Fuente
Journal of Ovarian Research|April 24, 2025
Platelet-rich plasma activation: are there differential effects in reproductive medicine?Eduardo Anitua, María de la Fuente, Roberto Prado, et al.
European Journal of Ophthalmology|March 18, 2020
Stability of freeze-dried plasma rich in growth factors eye drops stored for 3 months at different temperature conditionsEduardo Anitua, María de la Fuente, Francisco Muruzábal, et al.
Experimental Eye Research|December 16, 2020
Development and optimization of a personalized fibrin membrane derived from the plasma rich in growth factors technologyEduardo Anitua, María de la Fuente, Francisco Muruzabal, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Pharmaceutics|February 26, 2022
The Potential of Nanomedicine to Unlock the Limitless Applications of mRNALaura Taina-González, María de la Fuente
Cancer Letters|March 31, 2023
Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapiesJenifer García-Fernández, María de la Fuente Freire
Cryobiology|February 16, 2025
Long term stability of preservative-free and lyophilized PRGF eye drops stored at different temperature conditions: in vitro comparative studyEduardo Anitua, María de la Fuente, Mohammad Hamdan Alkhraisat
Macromolecular Bioscience|February 1, 2008
Novel hyaluronan-based nanocarriers for transmucosal delivery of macromoleculesMaría de la Fuente, Begoña Seijo, María J Alonso
Plos One|February 14, 2013
Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse plateletsAmal Arachiche, María de la Fuente, Marvin T Nieman
Plos One|May 17, 2014
Platelet specific promoters are insufficient to express protease activated receptor 1 (PAR1) transgene in mouse plateletsAmal Arachiche, María de la Fuente, Marvin T Nieman
Biotechnology Advances|June 7, 2015
Nanoengineering of vaccines using natural polysaccharidesAna Sara Cordeiro, María José Alonso, María de la Fuente
Journal of Ovarian Research|April 24, 2025
Platelet-rich plasma activation: are there differential effects in reproductive medicine?Eduardo Anitua, María de la Fuente, Roberto Prado, et al.
European Journal of Ophthalmology|March 18, 2020
Stability of freeze-dried plasma rich in growth factors eye drops stored for 3 months at different temperature conditionsEduardo Anitua, María de la Fuente, Francisco Muruzábal, et al.
Experimental Eye Research|December 16, 2020
Development and optimization of a personalized fibrin membrane derived from the plasma rich in growth factors technologyEduardo Anitua, María de la Fuente, Francisco Muruzabal, et al.
Pageof 12